49-year leukemia survivor: Why I support immunotherapy research at UT MD Anderson
I didn’t learn that Crystal Cruises was supporting UT MD Anderson’s immunotherapy research until I became a guest speaker for the cruise line in February 2026. But finding out that the company was donating a portion of its passengers’ booking fees to UT MD Anderson’s James P. Allison Institute™ through the end of 2026 was thrilling.
Why?
Because Dr. Allison won...
Liver cancer survivor thankful for immunotherapy clinical trial
When Gordon Drygalski was diagnosed with early-stage liver cancer in December 2023, several friends told him to go to UT MD Anderson for treatment...
Why getting an accurate lymphoma diagnosis matters
If you or a loved one has been diagnosed with lymphoma, you might think all you need to know is whether it’s Hodgkin or non-Hodgkin. But is...
Two-time tongue cancer survivor: Why I support research at UT MD Anderson
Sometimes, the most meaningful breakthroughs in medicine aren’t about saving your life — they’re about saving your quality of life. That was certainly the case for me when facing my second possible recurrence of tongue cancer in just six years in the spring of 2025.
By then, I’d already undergone two oral surgeries near my home in Pennsylvania. Each one came with its own set of frustrations...
Metastatic melanoma survivor trusts UT MD Anderson’s expertise and research
Joe Eastin was first diagnosed with melanoma on his left ear in 2012. The Dallas resident had surgery at home to treat the cancer and two...
Stage 4 cervical cancer survivor thankful for immunotherapy clinical trial
Looking back, Paulette Burkhart believes the fatigue she began experiencing in 2023 was not because she needed to take vitamins or get more...
Rare double-hit leukemia survivor: ‘Go straight to UT MD Anderson’
Normally, leukemia is a disease that strikes old people and babies. So, when I was diagnosed with chronic myeloid leukemia in ...
Immunotherapy and colorectal cancer: Where we are and what’s ahead
The immune system defends the body from viruses and bacteria. But it’s not as successful in killing cancer on its own. Immune checkpoint inhibitors...
Total neoadjuvant therapy: A new era for patients with locally advanced rectal cancer
When rectal cancer advances to involve nearby lymph nodes but hasn’t spread to other areas of the body, it’s considered to be locally advanced...
Understanding the different types of lymphoma
You may have already heard about non-Hodgkin lymphoma. But are there other kinds of lymphoma? What makes each one unique? And, are some symptoms...